Showing results (101-110 of 150) with videos related to
Sort By:
Pageof 15
Developmental and Comparative Immunology|July 20, 2011
Molecular characterization of nucleotide binding and oligomerization domain (NOD)-2, analysis of its inductive expression and down-stream signaling following ligands exposure and bacterial infection in rohu (Labeo rohita)B Swain, M Basu, B R Sahoo, et al.Cancer|May 2, 2013
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibodyBrian H Kushner, Shakeel Modak, Ellen M Basu, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1988
Purification and partial characterization of a receptor protein for mouse interferon gammaM Basu, J L Pace, D M Pinson, et al.Cancer|September 7, 2012
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literatureBrian H Kushner, Shakeel Modak, Kim Kramer, et al.Journal of Hematology & Oncology|November 27, 2025
Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II trialBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.Glycobiology|November 1, 1991
Biosynthesis in vitro of SA-Lex and SA-diLex by alpha 1-3 fucosyltransferases from colon carcinoma cells and embryonic brain tissuesM Basu, J W Hawes, Z Li, et al.JAMA Oncology|October 17, 2018
Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical TrialBrian H Kushner, Irene Y Cheung, Shakeel Modak, et al.Nucleic Acids Research|May 3, 2018
PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexesIshita Rehman, Suparna M Basu, Subhendu K Das, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1997
Mapping regions of herpes simplex virus type 1 glycoprotein I required for formation of the viral Fc receptor for monomeric IgGS Basu, G Dubin, T Nagashunmugam, et al.Oncoimmunology|November 18, 2017
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survivalIrene Y Cheung, Brian H Kushner, Shakeel Modak, et al.Pageof 15